498 related articles for article (PubMed ID: 19379084)
1. Epigenetic biomarkers in urothelial bladder cancer.
Kim WJ; Kim YJ
Expert Rev Mol Diagn; 2009 Apr; 9(3):259-69. PubMed ID: 19379084
[TBL] [Abstract][Full Text] [Related]
2. Genetic and epigenetic aspects of bladder cancer.
Kim WJ; Quan C
J Cell Biochem; 2005 May; 95(1):24-33. PubMed ID: 15759278
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic markers as promising prognosticators for bladder cancer.
Kim YK; Kim WJ
Int J Urol; 2009 Jan; 16(1):17-22. PubMed ID: 18721202
[TBL] [Abstract][Full Text] [Related]
4. Genetic and epigenetic biomarkers for early detection, therapeutic effectiveness and relapse monitoring in bladder cancer.
Dumache R; David D; Kaycsa A; Minciu R; Negru S; Puiu M
Rev Med Chir Soc Med Nat Iasi; 2011; 115(1):163-7. PubMed ID: 21682190
[TBL] [Abstract][Full Text] [Related]
5. Quantitation of promoter methylation of multiple genes in urine DNA and bladder cancer detection.
Hoque MO; Begum S; Topaloglu O; Chatterjee A; Rosenbaum E; Van Criekinge W; Westra WH; Schoenberg M; Zahurak M; Goodman SN; Sidransky D
J Natl Cancer Inst; 2006 Jul; 98(14):996-1004. PubMed ID: 16849682
[TBL] [Abstract][Full Text] [Related]
6. RUNX3 inactivation by point mutations and aberrant DNA methylation in bladder tumors.
Kim WJ; Kim EJ; Jeong P; Quan C; Kim J; Li QL; Yang JO; Ito Y; Bae SC
Cancer Res; 2005 Oct; 65(20):9347-54. PubMed ID: 16230397
[TBL] [Abstract][Full Text] [Related]
7. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract][Full Text] [Related]
8. Promoter hypermethylation identifies progression risk in bladder cancer.
Yates DR; Rehman I; Abbod MF; Meuth M; Cross SS; Linkens DA; Hamdy FC; Catto JW
Clin Cancer Res; 2007 Apr; 13(7):2046-53. PubMed ID: 17404085
[TBL] [Abstract][Full Text] [Related]
9. Prognostic relevance of methylation markers in patients with non-muscle invasive bladder carcinoma.
Friedrich MG; Chandrasoma S; Siegmund KD; Weisenberger DJ; Cheng JC; Toma MI; Huland H; Jones PA; Liang G
Eur J Cancer; 2005 Nov; 41(17):2769-78. PubMed ID: 16242928
[TBL] [Abstract][Full Text] [Related]
10. The role of deoxyribonucleic acid methylation in development, diagnosis, and prognosis of bladder cancer.
Gonzalgo ML; Datar RH; Schoenberg MP; Cote RJ
Urol Oncol; 2007; 25(3):228-35. PubMed ID: 17483020
[TBL] [Abstract][Full Text] [Related]
11. Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?
Kim YJ; Kim WJ
Investig Clin Urol; 2016 Jun; 57 Suppl 1(Suppl 1):S77-88. PubMed ID: 27326410
[TBL] [Abstract][Full Text] [Related]
12. Methylation of the RUNX3 promoter as a potential prognostic marker for bladder tumor.
Kim EJ; Kim YJ; Jeong P; Ha YS; Bae SC; Kim WJ
J Urol; 2008 Sep; 180(3):1141-5. PubMed ID: 18639281
[TBL] [Abstract][Full Text] [Related]
13. The role of epigenetic inactivation of 14-3-3sigma in human cancer.
Lodygin D; Hermeking H
Cell Res; 2005 Apr; 15(4):237-46. PubMed ID: 15857578
[TBL] [Abstract][Full Text] [Related]
14. Predicting favourable prognosis of urothelial carcinoma: gene expression and genome profiling.
van der Kwast TH; Bapat B
Curr Opin Urol; 2009 Sep; 19(5):516-21. PubMed ID: 19553819
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic changes in cancer.
Grønbaek K; Hother C; Jones PA
APMIS; 2007 Oct; 115(10):1039-59. PubMed ID: 18042143
[TBL] [Abstract][Full Text] [Related]
16. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
17. Action at a distance: epigenetic silencing of large chromosomal regions in carcinogenesis.
Clark SJ
Hum Mol Genet; 2007 Apr; 16 Spec No 1():R88-95. PubMed ID: 17613553
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic inactivation of ITIH5 promotes bladder cancer progression and predicts early relapse of pT1 high-grade urothelial tumours.
Rose M; Gaisa NT; Antony P; Fiedler D; Heidenreich A; Otto W; Denzinger S; Bertz S; Hartmann A; Karl A; Knüchel R; Dahl E
Carcinogenesis; 2014 Mar; 35(3):727-36. PubMed ID: 24265292
[TBL] [Abstract][Full Text] [Related]
19. Molecular markers in bladder cancer.
Shariat SF; Karam JA; Lerner SP
Curr Opin Urol; 2008 Jan; 18(1):1-8. PubMed ID: 18090481
[TBL] [Abstract][Full Text] [Related]
20. Molecular biomarkers in urothelial bladder cancer.
Kim WJ; Bae SC
Cancer Sci; 2008 Apr; 99(4):646-52. PubMed ID: 18377416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]